ScoreWhy is Pharmaids Pharmaceuticals Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -2.17% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.73 times
2
Risky - Negative EBITDA
- The company has recorded a negative EBITDA of Rs. -13.52 cr
- Over the past year, while the stock has generated a return of -53.78%, its profits have fallen by -33%
- The stock is trading risky as compared to its average historical valuations
3
Below par performance in long term as well as near term
- Along with generating -53.78% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pharmaids Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pharmaids Pharma
-53.03%
-1.05
51.39%
Sensex
-7.92%
-0.61
13.09%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.80%
EBIT Growth (5y)
-2.17%
EBIT to Interest (avg)
-7.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.25
Tax Ratio
29.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-24.61%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
2.01
EV to EBIT
-7.64
EV to EBITDA
-8.79
EV to Capital Employed
1.68
EV to Sales
4.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-21.94%
ROE (Latest)
-29.75%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
OPERATING PROFIT TO NET SALES(Q)
Highest at -4.74%
DEBTORS TURNOVER RATIO(HY)
Highest at 8.13 times
NET SALES(Q)
At Rs 7.18 cr has Grown at 38.7% (vs previous 4Q average
PBDIT(Q)
Highest at Rs -0.34 cr.
PBT LESS OI(Q)
Highest at Rs -1.47 cr.
PAT(Q)
Highest at Rs -1.72 cr.
EPS(Q)
Highest at Rs -0.51
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.13 cr
Loading Valuation Snapshot...
Here's what is working for Pharmaids Pharma
Operating Profit Margin - Quarterly
Highest at -4.74% and Grown
each quarter in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Net Sales - Quarterly
At Rs 7.18 cr has Grown at 38.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 5.18 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs -0.34 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs -1.47 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs -1.72 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs -0.51
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Highest at 8.13 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Pharmaids Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.13 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
